Home Infusion Therapy Market Revenue to Cross $35.69 Billion, Globally, by 2028 – Exclusive Report by The Insight Partners


The global home infusion therapy market size is growing from USD 21.76 billion in 2022 to USD 35.69 billion by 2028; it is estimated to record a CAGR of 8.6% from 2022 to 2028.

New York, Feb. 21, 2023 (GLOBE NEWSWIRE) — According to The Insight Partners, “Home Infusion Therapy Market Size, Share, Growth, Trends and Global Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors), Application (Anti-Infective, Endocrinology, Enteral Nutrition, Hydration Therapy, Chemotherapy, Specialty Pharmaceuticals, and Others), and Route of Administration (Intramuscular, Subcutaneously, and Epidural)”, the global home infusion therapy market growth is driven by increasing incidences of chronic disorders coupled with the rising geriatric population, and the reducing duration of hospital stays and the surging cost of care.


Download PDF Brochure at https://www.theinsightpartners.com/sample/TIPRE00004189

Global Home Infusion Therapy Market – Report Scope:

Market Size Value in USD 21.76 Billion in 2022
Market Size Value by USD 35.69 Billion by 2028
Growth rate CAGR of 8.6% from 2022 to 2028
Forecast Period 2022-2028
Base Year 2022
No. of Pages 221
No. of Tables 111
No. of Charts & Figures 82
Historical data available Yes
Segments covered Product, Application, and Route of Administration

Home Infusion Therapy Market Analysis: Competitive Landscape and Key Developments

B. Braun Melsungen AG, Micrel Medical Devices SA, Baxter International Inc, Nipro Corp, Becton Dickinson and Co, Fresenius Kabi AG, ICU Medical Inc, JMS Co Ltd, Eitan Medical Ltd, and Terumo Corp are a few of the key companies operating in the home infusion therapy market. The market leaders focus on new product launches, expansion and diversification, and acquisition strategies, which allow them to access prevailing business opportunities.

In November 2022, Fresenius Kabi inaugurated its 4th MedTech manufacturing facility at Parque Industrial Itabo (PIISA) in Haina, Dominican Republic. This new facility will add around 12,000 m² to the Fresenius Kabi MedTech footprint in Haina and is projected to add 700 to the current 4,600 employees. The state-of-the-art manufacturing facility will be equipped with automated assembly lines, installations, clean rooms, and laboratories needed for the manufacturing and development of disposables such as sets for infusion pumps and plasma collection.

In August 2022, Baxter International Inc announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its new Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, representing Baxter’s latest developments for infusion therapy. The Novum IQ SYR has the capability to fully integrate with hospital electronic medical records (EMRs) through Baxter’s IQ Enterprise Connectivity Suite.

In May 2022, Fresenius Kabi completed the acquisition of Ivenix, a manufacturer of infusion systems. Fresenius Kabi now offers health care professionals in the US a broad and expanding portfolio of advanced infusion pumps and solutions to meet needs across the continuum of care.

In January 2022, ICU Medical Inc announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of ~$2.5 billion. 

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00004189

Increasing Healthcare Potential of Developing Economies and Rising Prevalence of Healthcare-Associated Infections Provides Lucrative Opportunities for Global Home Infusion Therapy Market Growth:

Developing countries report a high prevalence of chronic diseases due to significant shifts in people’s lifestyles. Leading pharmaceutical companies have been focusing on increasing their reach across emerging markets by expanding their distribution networks and augmented manufacturing capabilities. Developing economies such as Brazil, India, China, Mexico, and South Africa offer potential growth opportunities to infusion therapy device manufacturers. This can be attributed to the large patient population, high chronic disease prevalence, and improved healthcare infrastructure. Moreover, as markets in the US and Europe are approaching maturity, most players have redirected their focus to emerging markets.

Additionally, patients are prone to hospital-acquired infections or healthcare-associated infections (HAIs) while receiving services in hospitals or other healthcare facilities. According to the Centers for Disease Control and Prevention (CDC), HAIs account for ~1.7 million infection cases and 99,000 deaths annually in American hospitals. Therefore, due to high HAIs and other risks, patient may require treatment and therapies in the homecare settings. Thus, the abovementioned factors are expected to provide lucrative opportunities for the home infusion therapy market in the coming years.

Check Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00004189

The US holds a significant share of the home infusion therapy market. The requirement for home and specialty infusion therapy has increased across the country due to the high prevalence of infections, gastrointestinal diseases and disorders, multiple sclerosis, rheumatoid arthritis, cancer, hemophilia, dehydration, congestive heart failure, immune deficiencies, and neurological disorders. According to a study by National Home Infusion Association (NHIA), in 2019, home infusion and alternate site providers catered to more than 3 million patients in the US, representing a 300% increase since the last industry study in 2008. Furthermore, in 2020, NHIA estimated that home and specialty infusion comprises over 900 providers serving 3.2 million patients annually in the country. Additionally, the presence of leading players, such as Baxter International Inc, Becton Dickinson and Co, and ICU Medical Inc, operating in the home infusion therapy market in the US and their role in product enhancement and market expansion are likely to favor the home infusion therapy market growth during the forecast period.

Global Home Infusion Therapy Market: Segmental Overview

Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. In 2022, the infusion pumps segment accounted for the largest market share. Also, the same segment is anticipated to register the highest CAGR during the forecast period as infusion pumps are widely used to give nutrition and administer medications to patients. The market for the infusion pumps segment is subsegmented into insulin pumps, elastomeric pumps, and syringe pumps. In 2022, the insulin pumps segment accounted for the largest market share. Based on application, the home infusion therapy market is segmented into anti-infective, endocrinology, enteral, specialty pharmaceuticals, hydration therapy, chemotherapy, and others. In 2022, the anti-infective segment held the largest share of the market. In contrast, the endocrinology segment is expected to register the highest CAGR from 2022 to 2028. Based on route of administration, the home infusion therapy market is segmented into intramuscular, subcutaneously, and epidural. In 2022, the intramuscular segment held the largest share of the home infusion therapy market, and it is also expected to register the highest CAGR from 2022 to 2028.

Buy Premium Copy of Home Infusion Therapy Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00004189

Impact of COVID-19 Pandemic on Global Home Infusion Therapy Market Growth:

The rising number of COVID-19 patients led to an overall positively impacted the home infusion therapy market. During the COVID-19 pandemic, home infusion providers were encouraged to participate in NHIA’s COVID-19 Home Infusion Therapy Program (C-HIT) by offering a home infusion of COVID-19 monoclonal antibodies. In 2021, the FDA authorized an Emergency Use Authorization (EUA) for monoclonal antibody IV therapy for COVID-19 patients. Monoclonal antibody therapy is directed to COVID-19 patients with mild to moderate symptoms. Intravenous (IV) therapy delivers medicines directly into the patient’s bloodstream. Monoclonal antibodies block viral attachment and entry into human cells to neutralize the virus. Additionally, IV vitamin drips were administered to COVID-19 patients for recovery. Thus, a significant number of FDA product approvals for home infusion therapy and IV drips for COVID-19 patients boosted the growth of the home infusion therapy market during the COVID-19 crisis.

Browse other research published by The Insight Partners:

Global Infusion Pumps Market Size to 2025 – Global Analysis and Forecasts By Type (Ambulatory Pumps, Volumetric Pumps, Syringe Pumps and Accessories), By Application (Diabetes, Chemotherapy, Gastrointestinal Diseases and Pediatrics) and End User (Hospitals & Clinics, Ambulatory Surgical Centers and Homecare) and Geography

Global Medical Infusion Warmers Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Portable Infusion Warmer, Fixed Infusion Warmer); Application (Intensive Care, Emergency Care, Others); End-user (Hospitals, Clinics, Ambulatory Services, Others) and Geography

Globa Infusion Pump Testers Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (Portable, Desktop); Application (Hospitals, Clinics, Others) and Geography

Global IV Infusion Pump Accessories Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Infusion Catheters, Valves, IV Sets, Cannulas, Tubing and Needles, Others); Application (Diabetes, Pain Management and Analgesia, Chemotherapy, Others); End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers, Others) and Geography

Global Pressure Infusion Devices Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Enteral Pump, Patient-controlled Analgesia (PCA) Pump, Insulin Pump); Type (Electrical, Mechanical); End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and Geography

Global Butterfly Infusion Sets Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (18 to 20-gauge, 21 to 24-gauge, 25 to 27-gauge); Application (Hospitals, Clinics, Other) and Geography

Global Syringe Infusion Pumps Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis by Type (Disposable, Reusable); Application (Hospitals, Surgery Centers, Specialty Centers, Others)

Global Analgesic Infusion Pumps Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Volumetric analgesia infusion pumps, Ambulatory analgesia infusion pumps, Syringe analgesia infusion pumps); Application (Post-Surgical Application, Accidents and Trauma, Labor pain, Cancer Patients, Others); End User (Hospitals, Clinics, Others) and Geography

Global Drugs Infusion System Market Size Forecast to 2028 – Covid-19 Impact and Global Analysis – by Product (Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia Pump, Insulin Pump, Implantable Infusion System); Mode of Administration (Oncology, Diabetes, Analgesia, Nutrition, Hematology, Pediatric, Others); Application (Intravenous, Subcutaneous, Arterial, Epidural, Others); End-User (Hospitals, Ambulatory Surgical Centers, Others.)

Global Infusion Manifolds Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis by Product ( 2 gang, 3 gang, 4 gang, 5 gang, others ); Application ( 3 way, 4 way ); End User ( hospitals, clinics, others)

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/home-infusion-therapy-market

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.